Initial Treatment With Bevacizumab in Choroidal Neovascularization Associated to High Myopia
Status:
Unknown status
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this protocol is to determine wether the initial protocol in the treatment of
subfoveal choroidal neovascularization associated to High Myopia with bevacizumab
intravitreal injections is more effective when using 3 doses vs using 1 single dose in the
load period
Phase:
Phase 3
Details
Lead Sponsor:
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA